share_log

Litchfield Hills Initiates Coverage On Mateon Therapeutics with Buy Rating, Announces Price Target of $3

Litchfield Hills Initiates Coverage On Mateon Therapeutics with Buy Rating, Announces Price Target of $3

Litchfield Hills以买入评级启动对Mateon治疗公司的覆盖,宣布目标价为3美元
Benzinga Real-time News ·  2020/12/07 07:25

Litchfield Hills initiates coverage on Mateon Therapeutics (OTC:MATN) with a Buy rating and announces Price Target of $3.

Litchfield Hills启动对Mateon Treeutics(OTC:材料),买入评级,并宣布目标价为3美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发